| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 5.7e-05 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -1.8e-05 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 1.8e-05 | 1 |